These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36174875)

  • 1. Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health.
    Lo Presti E; Nuzzo D; Al Mahmeed W; Al-Rasadi K; Al-Alawi K; Banach M; Banerjee Y; Ceriello A; Cesur M; Cosentino F; Firenze A; Galia M; Goh SY; Janez A; Kalra S; Kapoor N; Kempler P; Lessan N; Lotufo P; Papanas N; Rizvi AA; Sahebkar A; Santos RD; Stoian AP; Toth PP; Viswanathan V; Rizzo M;
    Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166559. PubMed ID: 36174875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothesized mechanisms explaining poor prognosis in type 2 diabetes patients with COVID-19: a review.
    Lisco G; De Tullio A; Giagulli VA; Guastamacchia E; De Pergola G; Triggiani V
    Endocrine; 2020 Dec; 70(3):441-453. PubMed ID: 32779091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
    Quirch M; Lee J; Rehman S
    J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Severe Acute Respiratory Syndrome Coronavirus 2 Antigen-Specific Systemic Immune Responses in Multisystem Inflammatory Syndrome in Children and Reversal After Recovery.
    Kumar NP; Venkataraman A; Nancy A; Moideen K; Varadarjan P; Selladurai E; Sangaralingam T; Selvam R; Thimmaiah A; Natarajan S; Ramasamy G; Hissar S; Radayam Ranganathan U; Babu S
    J Infect Dis; 2022 Sep; 226(7):1215-1223. PubMed ID: 35932220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome.
    Pandolfi L; Fossali T; Frangipane V; Bozzini S; Morosini M; D'Amato M; Lettieri S; Urtis M; Di Toro A; Saracino L; Percivalle E; Tomaselli S; Cavagna L; Cova E; Mojoli F; Bergomi P; Ottolina D; Lilleri D; Corsico AG; Arbustini E; Colombo R; Meloni F
    BMC Pulm Med; 2020 Nov; 20(1):301. PubMed ID: 33198751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and Mortality in COVID-19 Hospitalized Patients With and Without Type 2 Diabetes.
    Guo J; Lin WW; Zucker JE; Nandakumar R; Uhlemann AC; Wang S; Shivakoti R
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e1961-e1968. PubMed ID: 34999821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
    Han H; Ma Q; Li C; Liu R; Zhao L; Wang W; Zhang P; Liu X; Gao G; Liu F; Jiang Y; Cheng X; Zhu C; Xia Y
    Emerg Microbes Infect; 2020 Dec; 9(1):1123-1130. PubMed ID: 32475230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Network between Adipocytokines and Inflammatory Response in SARS-CoV-2 Infection: A Scoping Review.
    Nigro E; D'Agnano V; Quarcio G; Mariniello DF; Bianco A; Daniele A; Perrotta F
    Nutrients; 2023 Aug; 15(17):. PubMed ID: 37686837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast.
    Almerie MQ; Kerrigan DD
    Med Hypotheses; 2020 Oct; 143():109883. PubMed ID: 32492562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Underlying Co-Morbidity Reveals Unique Immune Signatures in Type II Diabetes Patients Infected With SARS-CoV2.
    Sengupta S; Bhattacharya G; Chatterjee S; Datey A; Shaw SK; Suranjika S; Nath P; Barik PK; Prasad P; Chattopadhyay S; Swain RK; Parida A; Devadas S
    Front Immunol; 2022; 13():848335. PubMed ID: 35572555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and the role of chronic inflammation in patients with obesity.
    Chiappetta S; Sharma AM; Bottino V; Stier C
    Int J Obes (Lond); 2020 Aug; 44(8):1790-1792. PubMed ID: 32409680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary: COVID-19 and obesity pandemics converge into a syndemic requiring urgent and multidisciplinary action.
    Hill MA; Sowers JR; Mantzoros CS
    Metabolism; 2021 Jan; 114():154408. PubMed ID: 33080269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An insight into the mechanisms of COVID-19, SARS-CoV2 infection severity concerning β-cell survival and cardiovascular conditions in diabetic patients.
    Srivastava A; Rockman-Greenberg C; Sareen N; Lionetti V; Dhingra S
    Mol Cell Biochem; 2022 Jun; 477(6):1681-1695. PubMed ID: 35235124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 and obesity: the meeting of two pandemics.
    Brandão SCS; Godoi ETAM; de Oliveira Cordeiro LH; Bezerra CS; de Oliveira Xavier Ramos J; de Arruda GFA; Lins EM
    Arch Endocrinol Metab; 2021 Nov; 65(1):3-13. PubMed ID: 33320454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral factors and the risk of viral infection: essential aspects during the COVID‑19 pandemic.
    Rychter AM; Zawada A; Szymczak-Tomczak A; Ratajczak AE; Dobrowolska A; Krela-Kaźmierczak I
    Pol Arch Intern Med; 2021 May; 131(5):455-463. PubMed ID: 33949188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms contributing to adverse outcomes of COVID-19 in obesity.
    Sudhakar M; Winfred SB; Meiyazhagan G; Venkatachalam DP
    Mol Cell Biochem; 2022 Apr; 477(4):1155-1193. PubMed ID: 35084674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.